Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mnemosyss is a patented marine-derived nutraceutical ingredient developed by Abyss Ingredients, a French company focused on circular economy and biotechnology. Formulated as a unique composition of marine peptides and omega-3 fatty acids, it is extracted from local fishing by-products using an eco-friendly, solvent-free water extraction process. Developed through the BrainBooster collaborative research project, Mnemosyss is designed as an oral dietary supplement to support cognitive health and general wellbeing, particularly in aging populations. It works by protecting the brain from age-related neuro-inflammation, facilitating the resolution of inflammatory processes, and improving the physiological management of the stress response, thereby preventing age-related memory deficits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mnemosyss.